参芪扶正注射液对急性非淋巴细胞白血病化疗患者免疫功能和生存质量的影响

Effects of shenqifuzheng injection on immune function and the quality of life in patients with acute nonlymphocytic leukemia

目的观察参芪扶正注射液对急性非淋巴细胞白血病(ANLL)化疗患者免疫功能及生存质量的影响。方法入选的80例ANLL患者分为两组,治疗组42例,采用参芪扶正注射液联合DA化疗方案治疗;对照组38例,单纯用DA化疗方案治疗。测定两组治疗前后血清免疫球蛋白IgA、IgG、IgM含量及淋巴细胞亚群CD3+♂、CD4+♂、CD4+♂/CD8+♂水平变化,并观察两组患者生存质量的改善情况。结果治疗组血清免疫球蛋白及CD3+♂、CD4+♂、CD4+♂/CD8+♂水平均高于对照组(P<0.05或P<0.01),对生活质量的改善亦优于对照组。结论参芪扶正注射液联合化疗可提高急性非淋巴细胞白血病患者的细胞免疫功能,改善其生活质量。

Aim To observe the effects of Shenqifuzheng injection（SFI）on enhancing immune function and improving the quality of life in patients with acute nonlymphocytic leukemia.Methods 80 patients were divided into 2 groups,the treatment group（n=32）treated with DA plus SFI,and the control group（n=28）treated with DA alone.The remission rate,clinical symptom and adverse reaction of two groups were observed.Meanwhile we observed the level of immunoglobulin（IgA,IgG,IgM）T lymphocyte subsets CD＋_3♂,CD＋_4♂,CD＋_4♂/ CD＋_8♂ in blood before and after treatment.We also observed the change of the quality of life in patients.Results In the treatment group,levels of immunoglobulin（IgA,IgG,IgM）and T lymphocyte subsets（CD＋_3♂,CD4＋,CD4＋/ CD8＋）were significantly higher in the treatment group than in the control group（P0.05）.Conclusion Shenqifuzheng injection combined with DA protocol on acute nonlymphocytic leukemia can enhance the immune function and improve the quality of life in patients with acute nonlymphocytic leukemia.